Role of Erythropoietin in 7,12-Dimethylbenz(a)anthracene Induction of Acute Chromosome Aberration and Leukemia in the Rat
AUTOR(ES)
Sugiyama, Taketoshi
RESUMO
The incidence of chromosome aberrations in rat bone marrow, examined 6 hr after the administration of 7,12-dimethylbenz(a)anthracene, was significantly enhanced by induction of anemia 0-48 hr before the carcinogen treatment and was suppressed by induction of polycythemia. The suppressive influence of polycythemia was reversed by sheep erythropoietin injected shortly before or after the carcinogen injection; this suppressive effect was proportional to the dose of erythropoietin used. These data suggest that erythropoietin is essential to make bone-marrow cells susceptible to chromosome aberrations with 7,12-dimethylbenz(a)anthracene. The incidence of carcinogen-induced leukemia was also increased by anemia and suppressed by polycythemia induction.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=389519Documentos Relacionados
- Induction of leukemia in rat by pulse doses of 7,12-dimethylbenz(a)anthracene.
- CHANGES IN CHROMOSOMES OF BONE MARROW AFTER INTRAVENOUS INJECTIONS OF 7,12-DIMETHYLBENZ(A)ANTHRACENE AND RELATED COMPOUNDS*
- Metabolism of 7,12-dimethylbenz[a]anthracene by Cunninghamella elegans.
- Metabolic pathways of 7,12-dimethylbenz[a]anthracene in hepatic microsomes.
- Effect of 7,12-Dimethylbenz[a]anthracene on Phagocytosis and Antibody Formation in Friend Virus Leukemia
